Cytokine release syndrome

There are 17 papers on cytokine release syndrome in aging research: 1 trial and 3 observational studies in people, 1 in animals, 1 in cells, 10 reviews. The newest story, Oct 4, 2026: “Electronic frailty index predicts CAR-T outcomes in older adults”.

Disease

17 papers study it4 more mention it4 findings

MeSH

See all 21 papers on cytokine release syndrome

“moderate/severe CRS (grade 1 with continuous fever or grade ≥2; β = -0.25, p = 0.03), and ICANS (any grade; β = -0.22, p = 0.04) were significantly associated with lower Δ6MWD.”
Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analysesEJHaem2024doi:10.1002/jha2.1043
  • Human trial1
  • Humans3
  • Animals1
  • Cells1
  • In silico1

Interventions

1

Rapamycin

downin reviews1

1 study
  1. Rapamycin decreases cytokine release syndrome in COVID-19 patients.

    Reviewin COVID-19 patients

More on Rapamycin

Effects

1

Physical function

downin humans1

1 study
  1. Cytokine release syndrome is linked with worse physical function in humans (grade 1 with continuous fever or grade >= 2) (β = -0.25, p = 0.03).

    Humansgrade 1 with continuous fever or grade >= 2

Associations

2

CAR-T cells

downin animals1

1 study
  1. CAR-T cells lower the risk of cytokine release syndrome.

    AnimalsGLP-1-secreting (MCAR T-2)

More on CAR-T cells

SARS-CoV-2 infection

upin humans1

1 study
  1. SARS-CoV-2 infection raises the risk of cytokine release syndrome in the elderly.

    Reviewin the elderly

More on SARS-CoV-2 infection

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 2Nov 2026: 04 papers in 12 months

See all 21 papers on cytokine release syndrome